{"id":"https://openalex.org/W2135686166","doi":"https://doi.org/10.1021/jm040071z","title":"Design of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with Improved Drug Resistance Properties. 1.","display_name":"Design of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with Improved Drug Resistance Properties. 1.","publication_year":2004,"publication_date":"2004-10-23","ids":{"openalex":"https://openalex.org/W2135686166","doi":"https://doi.org/10.1021/jm040071z","mag":"2135686166","pmid":"https://pubmed.ncbi.nlm.nih.gov/15537346"},"language":"en","primary_location":{"id":"doi:10.1021/jm040071z","doi":"https://doi.org/10.1021/jm040071z","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm040071z","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076759117","display_name":"Andrew L. Hopkins","orcid":"https://orcid.org/0000-0003-1977-018X","observed_orcids":["https://orcid.org/0000-0003-1977-018X"]},"institutions":[{"id":"https://openalex.org/I1336263701","display_name":"Centre for Human Genetics","ror":"https://ror.org/01rjnta51","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew L. Hopkins","raw_affiliation_strings":["Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058923877","display_name":"Jingshan Ren","orcid":"https://orcid.org/0000-0003-4015-1404","observed_orcids":["https://orcid.org/0000-0003-4015-1404"]},"institutions":[{"id":"https://openalex.org/I1336263701","display_name":"Centre for Human Genetics","ror":"https://ror.org/01rjnta51","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jingshan Ren","raw_affiliation_strings":["Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110028642","display_name":"John Milton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336263701","display_name":"Centre for Human Genetics","ror":"https://ror.org/01rjnta51","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Milton","raw_affiliation_strings":["Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056112208","display_name":"Richard J. Hazen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336263701","display_name":"Centre for Human Genetics","ror":"https://ror.org/01rjnta51","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard J. Hazen","raw_affiliation_strings":["Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110597524","display_name":"Joseph H. Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336263701","display_name":"Centre for Human Genetics","ror":"https://ror.org/01rjnta51","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joseph H. Chan","raw_affiliation_strings":["Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056016799","display_name":"David Ian Stuart","orcid":"https://orcid.org/0000-0002-3426-4210","observed_orcids":["https://orcid.org/0000-0002-3426-4210"]},"institutions":[{"id":"https://openalex.org/I1336263701","display_name":"Centre for Human Genetics","ror":"https://ror.org/01rjnta51","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David I. Stuart","raw_affiliation_strings":["Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109987940","display_name":"David K. STAMMERS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336263701","display_name":"Centre for Human Genetics","ror":"https://ror.org/01rjnta51","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David K. Stammers","raw_affiliation_strings":["Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK, Oxford Centre for Molecular Sciences, New Chemistry Building, University of Oxford, South Parks Road, Oxford, OX1 3QT, UK, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, U.K. and GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I1336263701","https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.5398,"has_fulltext":false,"cited_by_count":91,"citation_normalized_percentile":{"value":0.89114477,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"47","issue":"24","first_page":"5912","last_page":"5922"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hiv-1-reverse-transcriptase","display_name":"HIV-1 reverse transcriptase","score":0.9990000128746033},{"id":"https://openalex.org/keywords/quinolone-derivatives","display_name":"quinolone derivatives","score":0.8100000023841858},{"id":"https://openalex.org/keywords/drug-resistance-mutations","display_name":"drug resistance mutations","score":0.828000009059906},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.8740000128746033},{"id":"https://openalex.org/keywords/inhibitor-binding-mode","display_name":"inhibitor binding mode","score":0.5730000138282776},{"id":"https://openalex.org/keywords/antiretroviral-drug-resistance","display_name":"antiretroviral resistance","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.7709856629371643},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7581895589828491},{"id":"https://openalex.org/C2779922871","wikidata":"https://www.wikidata.org/wiki/Q426549","display_name":"Quinolone","level":3,"score":0.5839301347732544},{"id":"https://openalex.org/C153574943","wikidata":"https://www.wikidata.org/wiki/Q408939","display_name":"Nucleotidyltransferase","level":4,"score":0.538201093673706},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5177382826805115},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5078921914100647},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.4963093400001526},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.4911474883556366},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4431014657020569},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4409659504890442},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.410112202167511},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3947807252407074},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24324741959571838},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.21285593509674072},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2096422016620636},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20033758878707886},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19560998678207397},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13906607031822205},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.11971792578697205},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1021/jm040071z","doi":"https://doi.org/10.1021/jm040071z","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm040071z","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15537346","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15537346","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire_cris_publications/ac893e6d-062e-4921-9ff5-4cab3b9cf669","doi":null,"is_oa":false,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/ac893e6d-062e-4921-9ff5-4cab3b9cf669","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hopkins, A L, Ren, J, Milton, J, Hazen, R J, Chan, J H, Stuart, D I & Stammers, D K 2004, 'Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1', Journal of Medicinal Chemistry, vol. 47, no. 24, pp. 5912-5922. https://doi.org/10.1021/jm040071z","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.4000000059604645,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W49232095","https://openalex.org/W1165328265","https://openalex.org/W1569826234","https://openalex.org/W1591106880","https://openalex.org/W1627951033","https://openalex.org/W1873555895","https://openalex.org/W1883308443","https://openalex.org/W1963535341","https://openalex.org/W1964638418","https://openalex.org/W1964948559","https://openalex.org/W1969885133","https://openalex.org/W1970543338","https://openalex.org/W1973398091","https://openalex.org/W1981915870","https://openalex.org/W1995017064","https://openalex.org/W2007277999","https://openalex.org/W2009581957","https://openalex.org/W2011630381","https://openalex.org/W2018570817","https://openalex.org/W2022098233","https://openalex.org/W2022747839","https://openalex.org/W2024782634","https://openalex.org/W2025242673","https://openalex.org/W2030545030","https://openalex.org/W2030873574","https://openalex.org/W2035273655","https://openalex.org/W2038729300","https://openalex.org/W2043382734","https://openalex.org/W2054044810","https://openalex.org/W2055542167","https://openalex.org/W2059164290","https://openalex.org/W2060239134","https://openalex.org/W2063381239","https://openalex.org/W2067786897","https://openalex.org/W2068705423","https://openalex.org/W2068852852","https://openalex.org/W2070178355","https://openalex.org/W2073829104","https://openalex.org/W2075454202","https://openalex.org/W2076284523","https://openalex.org/W2077036660","https://openalex.org/W2077707065","https://openalex.org/W2080653934","https://openalex.org/W2081263792","https://openalex.org/W2084702672","https://openalex.org/W2086624754","https://openalex.org/W2090137444","https://openalex.org/W2090810359","https://openalex.org/W2092348839","https://openalex.org/W2093596482","https://openalex.org/W2096981707","https://openalex.org/W2099539543","https://openalex.org/W2102098015","https://openalex.org/W2102329750","https://openalex.org/W2103766655","https://openalex.org/W2116275717","https://openalex.org/W2117514600","https://openalex.org/W2117681036","https://openalex.org/W2117784959","https://openalex.org/W2126340181","https://openalex.org/W2130151135","https://openalex.org/W2130850997","https://openalex.org/W2136873830","https://openalex.org/W2142334951","https://openalex.org/W2150946329","https://openalex.org/W2161763737","https://openalex.org/W2163782658","https://openalex.org/W2181371485","https://openalex.org/W2188973184","https://openalex.org/W2423608760","https://openalex.org/W2916221768","https://openalex.org/W4231419782"],"related_works":["https://openalex.org/W2916221768","https://openalex.org/W1961441453","https://openalex.org/W2175108307","https://openalex.org/W4212974083","https://openalex.org/W2103389647","https://openalex.org/W2038790651","https://openalex.org/W1999577669","https://openalex.org/W2086624794","https://openalex.org/W2013435387","https://openalex.org/W4376618666"],"abstract_inverted_index":{"We":[0],"have":[1,55],"used":[2],"a":[3,8,21,59],"structure-based":[4],"approach":[5,53],"to":[6,49],"design":[7],"novel":[9,60],"series":[10,61,87],"of":[11,14,20,24,27,45,62,68,70,84],"non-nucleoside":[12],"inhibitors":[13,46],"HIV-1":[15,28,76],"RT":[16,77,97],"(NNRTIs).":[17],"Detailed":[18],"analysis":[19,67],"wide":[22],"range":[23],"crystal":[25],"structures":[26],"RT-NNRTI":[29],"complexes":[30,74],"together":[31],"with":[32,75],"data":[33],"on":[34],"drug":[35],"resistance":[36,94],"mutations":[37,95],"has":[38],"identified":[39],"factors":[40],"important":[41,93],"for":[42],"tight":[43],"binding":[44,81],"and":[47,57,100],"resilience":[48],"mutations.":[50],"Using":[51],"this":[52,85],"we":[54],"designed":[56],"synthesized":[58],"quinolone":[63,86],"NNRTIs.":[64],"Crystal":[65],"structure":[66],"four":[69],"these":[71],"compounds":[72],"in":[73,96],"confirms":[78],"the":[79,92],"predicted":[80],"modes.":[82],"Members":[83],"retain":[88],"high":[89],"activity":[90],"against":[91],"at":[98],"Tyr181Cys":[99],"Leu100Ile.":[101]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}